Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Decrease the prevalence of frailty syndrome in individuals with complete response of cancer.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| exercise and nutritional support | Experimental | exercise and nutritional support program during an active support phase (0 to 6 months) followed by an empowerment phase (from 6 to 12 months) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| exercise and nutritional support | Combination Product | exercise and nutritional support program during an active support phase (0 to 6 months) followed by an empowerment phase (from 6 to 12 months) |
| Measure | Description | Time Frame |
|---|---|---|
| Change of the prevalence of frailty syndrome in individuals with complete response of cancer | evolution of individual frailty during a multimodal intervention (physical and nutritional activity) according to the Fried's criteria | 0, 6 and 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| evaluation of predicitive variables of frailty syndrome reversion | The criterion determining the frail status is the Fried score classified into 3 categories: not frail; pre-frail; frail. A change from frail to pre-frail or to not frail will be considered as an improvement. Measurements of the Frailty score and other markers on nutrition and APA will be carried out at month 0 (basic measurements), then measured at month 6 (end of APA and nutritionist support) and at month12 (6 months after empowerment). All of health markers collected during the basic assessment, changes in parameters (month 6) and compliance with APA and nutrition support (from Month 1 to Month 6 then between Month 6 and Month 12) will be tested as variables potentially predictive of an improvement in the frailty syndrome. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Gaëtan Gavazzi, MD, PhD | Contact | (0)476765421 | +33 | ggavazzi@chu-grenoble.fr |
| Stéphane Mouret, PhD | Contact | (0)476767081 | +33 | smouret1@chu-grenoble.fr |
| Name | Affiliation | Role |
|---|---|---|
| Gaëtan Gavazzi, MD, PhD | University Hospital, Grenoble | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU de Grenoble | Recruiting | Grenoble | France |
Not provided
| ID | Term |
|---|---|
| D000073496 | Frailty |
| D009043 | Motor Activity |
| D009369 | Neoplasms |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| D018529 | Nutritional Support |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Month 0, 6 and 12 |
| Correlations between physical performance and frailty syndrome and their evolutions | measurement of VO2peak + ventilatory thresholds measured in a stress test, muscle strength/endurance (number of chair raises for 30 seconds), walking speed (10-meter walking test, 6-minute walk test), balance (Tinette score), coordination (functional mobility test), cardio-respiratory endurance (heart rate measurement in relation to pedaling power) | Month 0, 6 and 12 |
| Change from baseline nutritional status during nutritionist support (month 3 and 6) and at the end of empowerment (month 12) | nutritional parameters measured at each time frame for weight, VAS appetite score, MNA score, nutritional calculation (food survey and self-questionnaire), bio impedancemetry and biomarkers of nutrition (levels of albumin, prealbumin, C reactive protein, CBC, liver and kidney function) | Month 0, 3, 6 and 12 |
| Measure adherence to APA interventions and exercise practices | Adherence to APA support program throughout the study will be evaluated by measurements and sum of multiple parameters: number of sessions recorded on the heart rate monitor, average energy expenditure (in kcal) measured by the heart rate monitor,number of sets of exercises performed relative to the number of exercises recommended for muscle strengthening recorded in the patient notebook, CESS scale to assess beliefs about cancer patients and physical activity | between month 1 to 6 and between month 6 to 12 |
| Estimation of adherence to nutritional interventions | comparison between active support phase and empowerment phase with food self-questionnaire | Month 6 and 12 |
| Measure the durability of long-term activities | number of monthly patient connections to heart rate monitor; evaluation of the completion of patient notebook | Month 6 and 12 |
| Measure health related quality of life on mobility, personal autonomy, current activities, pain/discomfort and anxiety/depression | Assessment of quality of life with EQ-5D questionnaire by comparison to the basal state (M0). | Month 0, 6 and 12 |
| Sociological study on motivation: evaluation of the perception and experience of treating patients | a series of qualitative interviews with a panel of 15 patients, during 2 interview sessions: 1 after support phase and 1 at the end of autonomy phase. Interview will collect past/current socio-professional life, socialization in physical activity and nutrition. | Month 6 and 12 |
| D044623 | Nutrition Therapy |
| D013812 | Therapeutics |